Dallas, TX –– 9/16/15 – SWK Holdings Corporation (OTCQB: SWKH) (“SWK” or the “Company”), a life science focused specialty finance company, announced a clarification on the timing of the trading of the Company’s common stock on a post-split basis following the execution of the previously announced stock splits effective as of 5:00 p.m. on September 15, 2015.
The Financial Industry Regulatory Authority, Inc. (“FINRA”) had not yet issued an announcement regarding the Company’s common stock trading on a post-split basis when the market opened on September 16, 2015; and as a result, trading of the Company’s common stock was halted after briefly opening on September 16, 2015, on the OTCQB.
FINRA has reviewed the trading in SWK common stock for September 16, 2015, and has determined to rule all such transactions to be null and void.
FINRA has indicated that trading will resume 8:00:00 AM E.T. on Thursday, September 17, 2015, on a pre-split basis.
The Company’s common stock will trade on OTCQB on a post-split basis under CUSIP number 78501P 203 following announcement by FINRA. The Company expects an announcement regarding the timing of the Company’s post-split trading by FINRA shortly.
About SWK Holdings Corporation
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK’s business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. Additional information on the life science finance market is available on the Company’s website at www.swkhold.com.
Statements in this release that are not strictly historical and any statements regarding events or developments that we believe or anticipate will or may occur in the future are “forward-looking” statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2014 Annual Report on Form 10-K. These forward looking statements speak only as of the date of this release and the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
CONTACT: SWK Investor Relations ator firstname.lastname@example.org.